Back to MW MARSHALL WACE, LLP

CADLCADL
5 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CANDEL THERAPEUTICS INC

Yes. Marshall Wace holds 300,641 shares of CADL (Candel Therapeutics), worth $3.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$3.1M

Current Shares

300,641

Total Value Change

+$1.8M

Total Shares Change

+66,044

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
300,641
-
$3.1M0.0%$10.30
37
2025-Q4
Exited
0
-100.0%
$00.0%$5.71
0
2025-Q3
Decreased
103,847
-35.7%
$529,6210.0%$5.40
0
2025-Q2
Decreased
161,480
-31.2%
$817,0880.0%$4.90
0
2025-Q1
New
234,597
-
$1.3M0.0%$5.95
35

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used